Baseline characteristics and clinical presentation at hospital admission of study population
| Variables | Group A (10/10) (n=95) | Group B (10/5) (n=98) | All (n=193) | p Value |
|---|---|---|---|---|
| Age, years | 62.2±10.0 | 62.2±10.2 | 62.2±10.1 | 0.992 |
| Female gender | 13 (13.7) | 14 (14.3) | 27 (14.0) | 0.904 |
| Body mass index, kg/m2 | 27.5±3.3 | 27.2±3.6 | 27.3±3.4 | 0.505 |
| Body mass index ≥30 | 26 (27.4) | 20 (20.4) | 46 (23.8) | 0.311 |
| Diabetes mellitus | 29 (30.5) | 21 (21.4) | 50 (25.9) | 0.149 |
| Hyperlipidaemia | 48 (50.5) | 43 (43.9) | 91 (47.2) | 0.355 |
| Smoker | 29 (30.5) | 39 (39.8) | 68 (35.2) | 0.178 |
| Hypertension | 55 (57.9) | 56 (57.1) | 111 (57.5) | 0.916 |
| Previous MI | 24 (25.3) | 17 (17.3) | 41 (21.2) | 0.179 |
| Previous PCI | 32 (33.7) | 28 (28.6) | 60 (31.1) | 0.443 |
| Previous CABG | 5 (5.3) | 3 (3.1) | 8 (4.1) | 0.443 |
| Chronic renal failure | 8 (8.6) | 4 (4.1) | 12 (6.3) | 0.205 |
| LV ejection fraction (%) | 51.8±9.0 | 52.8±9.4 | 52.3±9.2 | 0.429 |
| LV ejection fraction ≤40% | 12 (12.6) | 12 (12.2) | 24 (12.4) | 0.935 |
| STEMI | 29 (30.5) | 27 (27.6) | 56 (29.0) | 0.649 |
Values are expressed as mean±SD or n (%).
MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; LV, left ventricular; STEMI, ST-elevation myocardial infarction.